Cargando…

Mortality From Ischemic Heart Disease: Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration

BACKGROUND: Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have been changes over time. METHODS AND RESULTS: We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowbar, Alexandra N., Gitto, Mauro, Howard, James P., Francis, Darrel P., Al-Lamee, Rasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613716/ https://www.ncbi.nlm.nih.gov/pubmed/31163980 http://dx.doi.org/10.1161/CIRCOUTCOMES.118.005375

Ejemplares similares

Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding
por: Nowbar, Alexandra N, et al.
Publicado: (2021)

2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United Nations
por: Nowbar, Alexandra N., et al.
Publicado: (2014)

Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
por: Chacko, Liza, et al.
Publicado: (2020)

Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial
por: McCreanor, Victoria, et al.
Publicado: (2021)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021)

Risk of harm from alcohol use and heavy alcohol consumption: Its association with other NCD risk factors in Thailand
por: Jakkaew, Nalinee, et al.
Publicado: (2019)

Guest Editorial: Strengthening NCD prevention through risk factor surveillance
por: Bonita, Ruth
Publicado: (2009)

Women and evaluation of inequalities in the distribution of risk factors for Chronic non-communicable diseases (NCD), Vigitel 2016–2017
por: Malta, Deborah Carvalho, et al.
Publicado: (2020)

Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022)

NCD epidemic and sexual reproductive health issues in the infectious disease world
por: Tumwine, James K
Publicado: (2019)

The Magnitude of NCD Risk Factors in Ethiopia: Meta-Analysis and Systematic Review of Evidence
por: Tesfay, Fisaha Haile, et al.
Publicado: (2022)

Non-communicable disease (NCD) risk factors and diabetes among adults living in slum areas of Dhaka, Bangladesh
por: Rawal, Lal B., et al.
Publicado: (2017)

Does published research on non-communicable disease (NCD) in Arab countries reflect NCD disease burden?
por: Sibai, Abla M., et al.
Publicado: (2017)

The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration
por: Aggarwal, Ajay, et al.
Publicado: (2020)

Association of metabolic NCD risk factors with oral, breast and cervical precancers and cancers in India
por: Kedar, Ashwini, et al.
Publicado: (2019)

High prevalence of HIV and non‐communicable disease (NCD) risk factors in rural KwaZulu‐Natal, South Africa
por: van Heerden, Alastair, et al.
Publicado: (2017)

Intersecting sex-related inequalities in self-reported testing for and prevalence of Non-Communicable Disease (NCD) risk factors in Kerala
por: Negi, Jyotsna, et al.
Publicado: (2022)

Achieving Optimal Medical Therapy: Insights From the ORBITA Trial
por: Foley, Michael, et al.
Publicado: (2021)

Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations()
por: Finegold, Judith A., et al.
Publicado: (2013)

Prevalence of smoking and high blood pressure, two major risk factors for non-communicable diseases: the SuRF NCD (surveillance of risk factors of non-communicable disease) report 2012
por: Jamalizadeh, Ahmad, et al.
Publicado: (2016)

Epidemiological study of non-communicable diseases (NCD) risk factors in tribal district of Kinnaur, HP: A cross-sectional study
por: Negi, Prakash Chand, et al.
Publicado: (2016)

The tide of dietary risks for noncommunicable diseases in Pacific Islands: an analysis of population NCD surveys
por: Reeve, Erica, et al.
Publicado: (2022)

Strategic investments in non-communicable diseases (NCD) research in Africa: the GSK Africa NCD Open Lab
por: Hall, Matthew D, et al.
Publicado: (2015)

JAPreventNCD
por: Klepp, K I
Publicado: (2023)

Distribution of lifespan gain from primary prevention intervention
por: Finegold, Judith A, et al.
Publicado: (2016)

Achieving optimal adherence to medical therapy by telehealth: Findings from the ORBITA medication adherence sub‐study
por: Thompson, David, et al.
Publicado: (2021)

Prevalence and associations of behavioural risk factors with blood lipids profile in Lebanese adults: findings from WHO STEPwise NCD cross-sectional survey
por: Mansour, Magali, et al.
Publicado: (2019)

S02-5 Physical inactivity in nine Eastern European and Central Asian countries: results from the WHO STEPwise approach to NCD risk factor surveillance
por: Whiting, Stephen, et al.
Publicado: (2022)

Effectiveness of NCD-Related Fiscal Policies: Evidence from the Pacific
por: Buksh, Shazna M., et al.
Publicado: (2023)

Pro-inflammatory diet, cardio-metabolic risk factors and risk of type 2 diabetes: A cross-sectional analysis using data from RaNCD cohort study
por: Namazi, Nazli, et al.
Publicado: (2023)

Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial( )
por: Ganesananthan, Sashiananthan, et al.
Publicado: (2022)

Opportunities and challenges to non-communicable disease (NCD) research and training in Pakistan: a qualitative study from Pakistan
por: Almas, Aysha, et al.
Publicado: (2022)

Fractional flow reserve derived from microcatheters versus standard pressure wires: a stenosis-level meta-analysis
por: Seligman, Henry, et al.
Publicado: (2019)

Daily angina documentation versus subsequent recall: development of a symptom smartphone app
por: Nowbar, Alexandra N, et al.
Publicado: (2022)

Is opium addiction a risk factor for ischemic heart disease and ischemic stroke?
por: Rezvani, Mohammad Reza, et al.
Publicado: (2012)

Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: results from the Asia Pacific Cohort Studies Collaboration
por: Peters, Sanne A E, et al.
Publicado: (2018)

Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study
por: Jam, Samira Arbabi, et al.
Publicado: (2022)

Risk factors for postoperative ischemic complications in pediatric moyamoya disease
por: Deng, Xiaofeng, et al.
Publicado: (2021)

Randomized Blinded Placebo-Controlled Trials of Renal Sympathetic Denervation for Hypertension: A Meta-Analysis
por: Ahmad, Yousif, et al.
Publicado: (2022)

Expanding access to non-communicable disease care in rural Malawi: outcomes from a retrospective cohort in an integrated NCD–HIV model
por: Wroe, Emily B, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_etf8sv3stn994edu44g0v3gapl